Annual EBITDA
-$66.37M$14.20M-27.21%
Summary
- Current Value
- As of today, ATYR annual EBITDA is -$66.37M, down -27.21% on
- Historical Performance
- ATYR annual EBITDA is down -102.91% over the past 3 years, and down -207.12% over the past 5 years
- All-Time High Comparison
- ATYR annual EBITDA is currently -450.41% below its historical high of -$12.06M set on
- 3-Year Low Comparison
- ATYR annual EBITDA is at its 3-year low
- Sector Comparison
- ATYR annual EBITDA is higher than 23.64% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$66.37M | -27.2% | -102.9% | -207.1% | -450.4% | |
| Quarterly EBITDA | -$26.36M | -48.4% | -101.5% | -324.3% | -360.2% | |
| TTM EBITDA | -$77.32M | -17.0% | -68.9% | -390.5% | -1250.0% | |
| Price | $0.72 | -81.8% | -71.0% | -80.5% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $235.00K | -33.4% | +100.0% | -44.3% | +100.0% | |
| Annual EPS | -$0.86 | +8.3% | +51.3% | +87.7% | +98.1% | |
| -$67.91M | -23.7% | -99.7% | -195.6% | -439.0% | ||
| Annual Net Income | -$64.02M | -27.0% | -89.5% | -169.4% | -263.6% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$44.71M | N/A | -48.5% |
| 5Y | -$14.65M | N/A | -353.2% |
| All | -$12.06M | -450.4% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$66.37M | at low | |
| 5Y | -$66.37M | at low | |
| All | -$66.37M | at low |
EBITDA History
FAQ
What is the current annual EBITDA of ATYR?
As of today, ATYR annual EBITDA is -$66.37M
What is 1-year change in ATYR annual EBITDA?
ATYR annual EBITDA is down -27.21% year-over-year
What is 3-year change in ATYR annual EBITDA?
ATYR annual EBITDA is down -102.91% over the past 3 years
How far is ATYR annual EBITDA from its all-time high?
ATYR annual EBITDA is currently -450.41% below its historical high of -$12.06M set on December 1, 2012
How does ATYR annual EBITDA rank versus sector peers?
ATYR annual EBITDA is higher than 23.64% of companies in Healthcare sector
When is ATYR next annual earnings release?
The next annual earnings release for ATYR is on
Quarterly EBITDA
-$26.36M$6.43M-32.27%
Summary
- Current Value
- As of today, ATYR quarterly EBITDA is -$26.36M, down -32.27% on
- Historical Performance
- ATYR quarterly EBITDA is down -48.44% year-over-year, and down -101.53% over the past 3 years
- All-Time High Comparison
- ATYR quarterly EBITDA is currently -1407.34% below its historical high of $2.02M set on
- 3-Year Low Comparison
- ATYR quarterly EBITDA is at its 3-year low
- Sector Comparison
- ATYR quarterly EBITDA is higher than 16.25% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$26.36M | -32.3% | -48.4% | -101.5% | -324.3% | |
| Annual EBITDA | -$66.37M | – | -27.2% | -102.9% | -207.1% | |
| TTM EBITDA | -$77.32M | -12.5% | -17.0% | -68.9% | -390.5% | |
| Price | $0.72 | -12.2% | -81.8% | -71.0% | -80.5% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $190.00K | +100.0% | +100.0% | +100.0% | +28.4% | |
| Quarterly EPS | -$0.27 | -22.3% | -16.4% | +42.6% | +61.3% | |
| -$26.75M | -31.7% | -47.4% | -98.2% | -310.7% | ||
| Quarterly Net Income | -$25.75M | -31.8% | -49.2% | -94.4% | -290.1% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$15.39M | -71.3% | |
| 3Y | -$7.25M | N/A | -263.4% |
| 5Y | -$4.69M | N/A | -461.5% |
| All | $2.02M | -1407.3% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$26.36M | at low | |
| 3Y | -$26.36M | at low | |
| 5Y | -$26.36M | at low | |
| All | -$26.36M | at low |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of ATYR?
As of today, ATYR quarterly EBITDA is -$26.36M
What is ATYR quarterly EBITDA most recent change?
ATYR quarterly EBITDA was down -32.27% on September 30, 2025
What is 1-year change in ATYR quarterly EBITDA?
ATYR quarterly EBITDA is down -48.44% year-over-year
How far is ATYR quarterly EBITDA from its all-time high?
ATYR quarterly EBITDA is currently -1407.34% below its historical high of $2.02M set on March 1, 2020
How does ATYR quarterly EBITDA rank versus sector peers?
ATYR quarterly EBITDA is higher than 16.25% of companies in Healthcare sector
When is ATYR next earnings release?
The next earnings release for ATYR is on
TTM EBITDA
-$77.32M$8.60M-12.52%
Summary
- Current Value
- As of today, ATYR TTM EBITDA is -$77.32M, down -12.52% on
- Historical Performance
- ATYR TTM EBITDA is down -16.96% year-over-year, and down -68.90% over the past 3 years
- All-Time High Comparison
- ATYR TTM EBITDA is currently -1250.04% below its historical high of -$5.73M set on
- 3-Year Low Comparison
- ATYR TTM EBITDA is at its 3-year low
- Sector Comparison
- ATYR TTM EBITDA is higher than 21.66% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$77.32M | -12.5% | -17.0% | -68.9% | -390.5% | |
| Annual EBITDA | -$66.37M | – | -27.2% | -102.9% | -207.1% | |
| Quarterly EBITDA | -$26.36M | -32.3% | -48.4% | -101.5% | -324.3% | |
| Price | $0.72 | -12.2% | -81.8% | -71.0% | -80.5% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $190.00K | +100.0% | -19.1% | +100.0% | -97.8% | |
| TTM EPS | -$0.83 | -4.7% | +10.9% | +49.4% | +68.5% | |
| -$78.65M | -12.3% | -15.6% | -67.0% | -364.5% | ||
| TTM Net Income | -$75.13M | -12.7% | -17.7% | -62.0% | -331.1% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$65.72M | -17.6% | |
| 3Y | -$43.88M | -76.2% | |
| 5Y | -$14.85M | N/A | -420.8% |
| All | -$5.73M | -1250.0% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$77.32M | at low | |
| 3Y | -$77.32M | at low | |
| 5Y | -$77.32M | at low | |
| All | -$77.32M | at low |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of ATYR?
As of today, ATYR TTM EBITDA is -$77.32M
What is ATYR TTM EBITDA most recent change?
ATYR TTM EBITDA was down -12.52% on September 30, 2025
What is 1-year change in ATYR TTM EBITDA?
ATYR TTM EBITDA is down -16.96% year-over-year
How far is ATYR TTM EBITDA from its all-time high?
ATYR TTM EBITDA is currently -1250.04% below its historical high of -$5.73M set on March 1, 2014
How does ATYR TTM EBITDA rank versus sector peers?
ATYR TTM EBITDA is higher than 21.66% of companies in Healthcare sector
When is ATYR next earnings release?
The next earnings release for ATYR is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- ATYR Official Website atyrpharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1339970/000119312525269587/0001193125-25-269587-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1339970/000095017025038888/0000950170-25-038888-index.htm
- ATYR Profile on Yahoo Finance finance.yahoo.com/quote/ATYR
- ATYR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/atyr